Mayo Clinic and Clarapath Collaborate to Advance Pathology Tissue Processing
Mayo Clinic is collaborating with Clarapath to address labor shortages and the increasing volume of tissue specimens in pathology labs.
Mayo Clinic is collaborating with Clarapath to address labor shortages and the increasing volume of tissue specimens in pathology labs.
Clinicians can now use two new biomarker-based assays in combination to determine which patients are at higher risk for poor outcomes.
Scopio Labs received De Novo clearance from the FDA for its Full-Field Bone Marrow Aspirate (FF-BMA) Application.
Verichem Laboratories upgraded its web-based, CLIA-compliant data reduction and test reporting software program.
Unilabs will use the SOPHiA DDM Platform to test for Homologous Recombination Deficiency in solid tumors, particularly in ovarian cancer.